{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:16:56Z","timestamp":1790795816022,"version":"4.1.0"},"reference-count":38,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Fibroblast activation protein (FAP) is a cell surface glycoprotein expressed by myofibroblastic cells in areas of active tissue remodeling, such as wound healing, fibrosis, and certain chronic inflammatory lesions. As FAP is uniquely present in chronic inflammatory lesions and has an important role in extracellular matrix (ECM) turnover, it appears to have all the characteristics necessary for involvement in atherosclerosis and atherosclerotic plaque rupture and has become a potential target in the treatment of myocardial infarction. Methods: To further understand the role of FAP, its expression in atherosclerotic plaques was examined in a genetically modified mouse model of accelerated atherosclerosis (Apobec1 \u2212\/\u2212 Ldlr \u2212\/\u2212 double-knockout mice). The immunohistochemical Fap staining of atherosclerotic plaques in a mouse model of atherosclerosis was correlated with quantification of Fap mRNA obtained from the atherosclerotic plaques of the aortic arch. Fap distribution was characterized in mouse atherosclerotic plaques relative to other markers of activated smooth muscle cells, such as alpha smooth muscle actin and myosin heavy chain (Acta2 and Myh2), ECM turnover (Ki-67, procollagen III and Mmp-9), and inflammation in atherosclerosis (Cd-44, Il-12 and Tgf beta) using immunohistochemistry (IH) and RT-PCR analysis. Results: The mouse model of accelerated atherosclerosis showed an increasing presence of Fap with the progression of atherosclerosis and a high expression level in advanced atherosclerotic lesions compared with other markers of ECM turnover and inflammation in atherosclerosis. Conclusions: FAP exhibits a distinct pattern of expression in a mouse model of atherosclerosis as compared to other markers of activated vascular smooth muscle cells, ECM degeneration, and inflammatory cytokines.<\/jats:p>","DOI":"10.3390\/metabo15040243","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T07:47:44Z","timestamp":1743580064000},"page":"243","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fibroblast Activation Protein Compared with Other Markers of Activated Smooth Muscle Cells, Extracellular Matrix Turnover and Inflammation in a Mouse Model of Atherosclerosis"],"prefix":"10.3390","volume":"15","author":[{"given":"Adam","family":"Mohmand-Borkowski","sequence":"first","affiliation":[{"name":"Department of Cardiology, Cape Cod Hospital, Hyannis, MA 02601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dareus O.","family":"Conover","sequence":"additional","affiliation":[{"name":"School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104-6304, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Rozmyslowicz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/joim.12367","article-title":"Regulation of atherosclerotic plaque inflammation","volume":"278","author":"Weber","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12296","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"276","author":"Badimon","year":"2014","journal-title":"J. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e005543","DOI":"10.1161\/JAHA.117.005543","article-title":"Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives","volume":"6","author":"Stefanadis","year":"2017","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2020.03.024","article-title":"Basic Biology of Extracellular Matrix in the Cardiovascular System, Part 1\/4: JACC Focus Seminar","volume":"75","author":"Fischer","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2020.03.020","article-title":"Extracellular Matrix in Ischemic Heart Disease, Part 4\/4: JACC Focus Seminar","volume":"75","author":"Frangogiannis","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MOL.0000000000000112","article-title":"Collagen and related extracellular matrix proteins in atherosclerotic plaque de-velopment","volume":"25","author":"Shami","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2613.2000.00155.x","article-title":"The extracellular matrix can regulate vascular cell migration, proliferation, and survival: Relationships to vascular disease","volume":"81","author":"Raines","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0008-6363(98)00321-6","article-title":"Collagen synthesis in atherosclerosis: Too much and not enough","volume":"41","author":"Rekhter","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.matbio.2017.12.003","article-title":"Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts","volume":"67","author":"Avery","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_12","first-page":"476","article-title":"Signaling mechanism regulating fibroblast activation, phenoconversion and fibrosis in the heart","volume":"51","author":"MacLean","year":"2014","journal-title":"Indian. J. Biochem. Biophys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.phrs.2015.07.001","article-title":"Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions","volume":"101","author":"Vivar","year":"2015","journal-title":"Pharmacol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-39369-y","article-title":"Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype","volume":"13","author":"Hall","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","article-title":"Effect of fibroblast activation protein and alpha2-antiplasmin cleaving en-zyme on collagen types I, III and IV","volume":"457","author":"Christiansen","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1074\/jbc.M511112200","article-title":"Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity","volume":"281","author":"Edosada","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1074\/mcp.RA118.001046","article-title":"Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2004.08.030","article-title":"Macrophage migration inhibitory factor induces MMP-9 expression: Implications for destabilization of human atherosclerotic plaques","volume":"178","author":"Kong","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","article-title":"Fibroblast activation protein is induced by inflammation and de-grades type I collagen in thin cap fibroatheromata","volume":"32","author":"Brokopp","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3390\/molecules20022081","article-title":"Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging","volume":"20","author":"Meletta","year":"2015","journal-title":"Molecules"},{"key":"ref_21","first-page":"5","article-title":"Expression of fibroblast activation protein in human coronary vessels","volume":"49","author":"Rozmyslowicz","year":"2021","journal-title":"Pol Merkur Lek."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mohmand-Borkowski, A., and Rozmyslowicz, T. (2024). Immunohistochemical Localization of Fibroblast Activation Protein in Coronary Arteries with Different Forms of Atherosclerosis. Metabolites, 14.","DOI":"10.3390\/metabo14110573"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/cvr\/cvaa142","article-title":"Deletion of fibroblast activation protein provides atheroprotection","volume":"117","author":"Stein","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ajpath.2020.01.004","article-title":"Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner","volume":"190","author":"Monslow","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_25","first-page":"293","article-title":"Quantification of Atherosclerosis in Mice","volume":"209","author":"Daugherty","year":"2003","journal-title":"Methods Mol. Biol."},{"key":"ref_26","first-page":"e50933","article-title":"Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus","volume":"82","author":"Banko","year":"2013","journal-title":"J. Vis. Exp"},{"key":"ref_27","first-page":"1395","article-title":"The availability of the fibroblast activation protein receptor in early identification of vulnera-ble atherosclerotic plaques: A preclinical study using a 68Ga-FAPI PET","volume":"62","author":"Wang","year":"2021","journal-title":"J. Nuc. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cpet.2023.03.004","article-title":"Cardiac Applications of Fibroblast Activation Protein Imaging","volume":"18","author":"Diekmann","year":"2023","journal-title":"PET Clin."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cui, Y., Wang, Y., Wang, S., Du, B., Li, X., and Li, Y. (2023). Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases. J. Clin. Med., 12.","DOI":"10.3390\/jcm12186033"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","article-title":"Molecular imaging of arterial fibroblast activation protein: Association with calcified plaque burden and cardiovascular risk factors","volume":"50","author":"Kosmala","year":"2023","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132044","DOI":"10.1016\/j.ijcard.2024.132044","article-title":"Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation","volume":"406","author":"Tillmanns","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.ijcard.2013.06.061","article-title":"Circulating concentrations of fibroblast activation protein \u03b1 in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA","volume":"168","author":"Tillmanns","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2017.01.037","article-title":"Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI","volume":"232","author":"Tillmanns","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2014.10.091","article-title":"Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin","volume":"178","author":"Malfliet","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1016\/S0735-1097(24)06392-7","article-title":"Cardiac fibroblast activation after acute coronary syndrome detected by 99MTCIFAP spect, multimodality approach and follow up","volume":"83","author":"Hernandez","year":"2024","journal-title":"J. Am. Coll. Card."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11886-023-01869-8","article-title":"The Potential of Fibroblast Activation Protein-Targeted Imaging as a Biomarker of Cardiac Remod-eling and Injury","volume":"25","author":"Moyola","year":"2023","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2021.02.019","article-title":"Molecular Imaging Identifies Fibroblast Activation Beyond the Infarct Region After Acute Myocardial Infarction","volume":"77","author":"Diekmann","year":"2021","journal-title":"J. Am. Coll. Card."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/4\/243\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:08:40Z","timestamp":1760029720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/4\/243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["metabo15040243"],"URL":"https:\/\/doi.org\/10.3390\/metabo15040243","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]}}}